share_log

Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16

Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16

富國銀行維持對BrightSpring Health的增持,將目標股價上調至16美元
Benzinga ·  05/06 09:52

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $15 to $16.

富國銀行分析師斯蒂芬·巴克斯特維持BrightSpring Health(納斯達克股票代碼:BTSG)增持,並將目標股價從15美元上調至16美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論